AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Ashoka Whiteoak Emerging Markets Trust PLC

Annual Report Dec 14, 2023

9354_ir_2023-12-14_4616175d-ffe9-40d6-8ee9-5eea82c9b23e.pdf

Annual Report

Open in Viewer

Opens in native device viewer

Ashoka WhiteOak Emerging Markets Trust plc

(Company registration number 14732678)

Initial Audited Report and Accounts prepared in accordance with Section 839 of the Companies Act 2006.

For the period from incorporation on 15 March 2023 to 30 September 2023

CONTENTS PAGE

CONTENTS PAGE
DIRECTORS, INVESTMENT MANAGER AND ADVISORS
REPORT OF THE INDEPENDENT AUDITOR
STATEMENT OF COMPREHENSIVE INCOME
STATEMENT OF FINANCIAL POSITION
STATEMENT OF CHANGES IN EQUITY
STATEMENT OF CASH FLOWS
NOTES TO THE FINANCIAL STATEMENTS
ALTERNATIVE PERFORMANCE MEASURES (unaudited)

DIRECTORS, INVESTMENT MANAGER AND ADVISORS

,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Directors
Martin Shenfield (Chair & Nominations Committee Chair)
Howard Pearce (Audit Committee Chair)
Tanit Curry (Management Engagement Committee Chair)
Investment Manager and AIFM Acorn Asset Management Ltd (Acorn)
4 th Floor, 19 Bank Street
Cybercity, Ebene 72201
Republic of Mauritius
Investment Adviser White Oak Capital Partners Pte, Ltd (WhiteOak)
3 Church Street
#22-04 Samsung Hub
Singapore 049483
Broker Ellora Partners
10 Old Burlington Street
London W1S 3AG
Bankers & Custodian HSBC Bank
8 Canada Square
London E14 5HQ
Auditors Ernst & Young LLP (EY)
25 Churchill Place
Canary Wharf
London E14 5EY
Registrar Computershare Investor Services PLC (Computershare)
The Pavilions
Bridgwater Road
Bristol BS99 6AH
Company Secretary & Administrator JTC (UK) Limited
The Scalpel, 18 th Floor
52 Lime Street
London EC3M 7AF
Legal Adviser Stephenson Harwood LLP
1 Finsbury Circus
London EC2M 7SH
Registered Office The Scalpel, 18 th Floor
52 Lime Street
London EC3M 7AF
Registered Number 14732678
LEI Number 254900Z4X5Y7NTODRI75
Company Website https://awemtrust.com

REPORT OF THE INDEPENDENT AUDITOR TO ASHOKA WHITEOAK EMERGING MARKETS TRUST PLC (under Section 839(5) of the Companies Act 2006)

Opinion

We have examined the initial accounts of Ashoka WhiteOak Emerging Markets Trust Plc ('the Company') for the period from 15 March 2023 to 30 September 2023 which comprise the statement of Comprehensive Income, the statement of Financial Position, the statement of Changes in Equity and Statement of Cash Flows and the related notes 1 to 20. The initial accounts have been prepared under the accounting policies set out therein.

In our opinion the initial accounts for the period from 15 March 2023 to 30 September 2023 have been properly prepared within the meaning of section 839(4) of the Companies Act 2006.

Respective responsibilities of Directors and auditors

The Directors are responsible for the preparation of the initial accounts in accordance with applicable United Kingdom law and Accounting Standards (UK-adopted international accounting standards).

Our responsibility is to report to you our opinion as to whether the initial accounts have been properly prepared within the meaning of section 839(4) of the Companies Act 2006.

Use of our report

This report is made solely to the Company's members, as a body, in accordance with Section 839(5) of the Companies Act 2006 and for no other purpose. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.

Mike Gaylor (Senior Statutory Auditor) For and on behalf of Ernst & Young LLP, Statutory Auditor

25 Churchill Place Canary Wharf London E14 5EY

13 December 2023

STATEMENT OF COMPREHENSIVE INCOME

For the period 15 March 2023 to 30 September 2023

Revenue Capital Total
Notes £ £ $\mathbf{f}$
Income
Net gain on investments held at fair value through
profit and loss
6 $\blacksquare$ 1,046,780 1,046,780
Income $\overline{7}$ 192,613 192,613
$\omega_{\rm{max}}$ and $\omega_{\rm{max}}$
Total Income 192,613 1,046,780 1,239,393
Expenses
Administrative and other expenses 8 (312, 401) $\sim 100$ (312, 401)
Total expenses (312, 401) $\sim 100$ (312, 401)
Profit/(loss) before taxation (119, 788) 1,046,780 926,992
Taxation (153, 976) (153, 976)
Profit/(loss) after tax and Total Comprehensive
Income for the period (273, 764) 1,046,780 773,016
Earnings per share (basic and diluted) $(0.90)$ p 3.42p 2.53p

All Revenue and Capital items in the above statement are derived from continuing operations.

The "Total" column of this statement is the profit and loss account of the Company prepared in accordance with UK adopted international accounting standards. The supplementary revenue and capital columns are presented for information purposes in accordance with the Statement of Recommended Practice issue by the Association of Investment Companies.

The return on ordinary activities after taxation is the total comprehensive income and therefore no additional statement of other comprehensive income is presented.

The notes on pages 8 to 22 form an integral part of these Financial Statements.

STATEMENT OF FINANCIAL POSITION

As at 30 September 2023

Notes As at 30 September 2023
£
Non-current assets
Investments held at fair value through profit or loss 11 29,490,772
Current assets
Cash and cash equivalents 12 1,573,414
Trade and other receivables 13 206,311
1,779,725
Total assets 31,270,497
Non-current liabilities
Capital gains tax provision (83, 385)
Current liabilities
Trade and other payables 14 (364,095)
Total liabilities (447, 480)
Net assets 30,823,017
Shareholders' Equity
Share capital 17 355,323
Revenue reserve (273, 764)
Capital reserve 1,046,780
Capital reduction reserve 29,694,678
Total equity 30,823,017
Net asset value per ordinary share 100.79p

The notes on pages 8 to 22 form an integral part of these Financial Statements.

The Initial accounts, prepared in accordance with S839 of Companies Act were approved by the board of directors and signed on its behalf by:

DocuSianed by Martin Shenfield -412721D242C7441...

Martin Shenfield Chairman 13 December 2023

STATEMENT OF CHANGES IN EQUITY

For the period 15 March 2023 to 30 September 2023

Share
Capital
Share
Premium
Revenue
Reserve
Capital
Reserve
Capital
reduction
reserve
Total
Notes £ $\mathbf f$ $\mathbf f$ £ £ £
Opening balance as
at 15 March 2023
Transaction with
owners:
Issue of Ordinary
shares
IPO (Initial Public
17 355,323 30,226,957 30,582,280
Offering) Costs
Transfer from share
premium to capital
$\overline{\phantom{a}}$ (532, 279) $\qquad \qquad \blacksquare$ (532, 279)
reduction reserve (29,694,678) 29,694,678
Profit for the period (273, 764) 1,046,780 773,016
Closing balance as at
30 September 2023
355,323 (273, 764) 1,046,780 29,694,678 30,823,017

The notes on pages 8 to 22 form an integral part of these Financial Statements.

The Company's distributable reserves consist of the Revenue Reserve and the Capital reduction reserve.

STATEMENT OF CASH FLOWS

For the period ended 30 September 2023

For the period 15
March 2023 to 30
September 2023
£
Cash flows from operating activities
Profit/(loss) after tax 773,016
Adjustment for:
- Net income from financial assets at fair value
through profit or loss (1,046,780)
Operating loss before working capital changes (273, 764)
Increase in trade and other receivables (82, 946)
Increase in trade and other payables 195,188
Increase in capital gains tax provision 83,385
Net cash from operating activities (78, 137)
Cash flows from/(used in) investing activities
Payment for purchases of investments (57, 910, 645)
Proceeds from sale of investments 29,512,195
Net cash (used in) investing activities (28, 398, 450)
Cash flows from/(used in) financing activities
IPO Cost (532, 279)
Proceeds on issue of shares 30,532,280
Management shares 50,000
Net cash flow from financing activities 30,050,001
Net increase in cash and cash equivalents 1,573,414
Cash and cash equivalents at the beginning of the
period
Cash and cash equivalents at the end of the period 1,573,414

The notes on pages 8 to 22 form an integral part of these Financial Statements.

NOTES TO THE FINANCIAL STATEMENTS

1. General Information

Ashoka WhiteOak Emerging Markets Trust Plc is a public limited company, registered and incorporated in England and Wales on 15 March 2023. The Company's registered office is 18th Floor, The Scalpel, 52 Lime Street, London, United Kingdom, EC3M 7AF. Business operations commenced on 3 May 2023 when the Company's Ordinary Shares were admitted to trading on the London Stock Exchange. Its share capital is denominated in British Pounds Sterling $(E)$ and currently consists of ordinary shares. The Initial audited report and accounts (the "Financial Statements") of the Company are presented for the period from 15 March 2023 to 30 September 2023.

The Company shall invest primarily in securities admitted to trading on any stock exchange (which may include stock exchanges in Developed Markets) that provide exposure to companies that are domiciled in Global Emerging Markets (EMs), or that are domiciled in Developed Markets but at the time of investment, derive a majority of their economic value, revenues or profits from, or whose assets or cost base are mainly located in EMs.

2. Basis of preparation

Statement of compliance

The Financial Statements have been prepared in accordance with UK-adopted International Accounting Standards (IAS) and in conformity with the requirements of the Companies Act 2006 and also considers the Statement of Recommended Practice "Financial Statements of Investment Trust Companies and Venture Capital Trusts", issued by the Association of Investment Companies, (the AIC (Association of Investment Companies) SORP) in July 2022. The Financial Statements are initial accounts prepared under requirements of section 839(4) of the Companies Act. The initial Financial Statements have been prepared on the historical cost basis except for financial instruments at fair value through profit or loss, which are measured at fair value.

The principal accounting policies are set out in Note 5.

In terms of the AIC SORP, the Company presents an Income Statement which shows amounts split between those which are revenue and capital in nature. The determination of the revenue or capital nature of a transaction is determined by considering the underlying elements of the transaction. Capital transactions are considered to be those arising as a result of the appreciation or depreciation in the value of assets due to the fair value movements on investments held at fair value through profit and loss. Revenue transactions are all transactions, other than those which have been identified as capital in nature.

The Financial Statements are also prepared on the assumption that approval as an investment trust will continue to be granted.

Functional and presentation currency

The Financial Statements are prepared in sterling, which is the functional currency of the Company which is also the presentation currency. Monetary amounts in these Financial Statements are rounded to the nearest pound.

Comparatives

There are no comparatives as this is the Company's first accounting period.

2. Basis of preparation (continued)

Going concern

The Directors have adopted the going concern basis in preparing the Financial Statements.

The financial position of the Company, its cash flows, and liquidity position are described in the Financial Statements and related notes. In addition, note 16 to the Financial Statements includes the policies and processes for managing its capital, its financial risk management, details of its financial instruments and its exposure to credit risk and liquidity risk. The Directors consider the Company to have adequate resources to continue in operational existence for at least 12 months from the date of signing up to 31 December 2024.

As such, they have adopted the going concern basis in preparing the Financial Statements.

3. Use of estimates and judgements

The preparation of the Financial Statements requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates.

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimates are revised and in any future periods affected.

There are no significant judgements, estimates and assumptions included in these Financial Statements.

4. New and revised standard and interpretations

New and revised IFRSs in issue but not yet effective

A number of new standards, amendments to standards and interpretations are effective for the annual periods beginning on or after 1 January 2024. None of these are expected to have a material impact on the measurement of the amounts recognised in the financial statements of the Company

5. Accounting policies

The accounting policies used in the preparation of the Financial Statements have been consistently applied during the period ended 30 September 2023.

The principal accounting policies applied in the preparation of the Financial Statements are set out below.

(a) Income

Dividend income from shares is accounted for on the basis of ex-dividend dates. Overseas income is grossed up at the appropriate rate of tax.

Special dividends are assessed on their individual merits and may be credited to the Statement of Comprehensive Income as a capital item if considered to be closely linked to reconstructions of the investee company or other capital transactions.

All other investment income is credited to the Statement of Comprehensive Income as a revenue item within the "Revenue" column.

Interest on fixed income instruments is accounted on an accrual basis.

5. Accounting policies (continued)

(b) Foreign currency

Transactions denominated in foreign currencies are translated into sterling at actual exchange rates as at the date of the transaction. Any gain or loss arising from a change in exchange rates subsequent to the date of the transaction is included as an exchange gain or loss to capital or revenue in the Statement of Comprehensive Income as appropriate. Foreign exchange movements on investments are included in the Statement of Comprehensive Income within "Net gains /(losses)".

(c) Reserves

Capital reserves

Profits achieved in cash by selling investments and changes in fair value arising upon the revaluation of investments that remain in the portfolio are all charged to the capital column of the Statement of Comprehensive Income and allocated to the capital reserve.

(d) Expenses

Operating expenses are the Company's costs incurred in connection with the on-going management of the Company's investments and administrative costs.

All expenses are accounted for on an accrual basis. Expenses are recognised through the Statement of Comprehensive Income as revenue items except those which are capital in nature, these include those which are incidental to the acquisition, disposal or enhancement of an investment, which are accounted for as capital items in the Statement of Comprehensive Income.

Performance fees

Performance fees, if any, are payable directly by reference to the capital performance of the Company and are therefore charged to the Statement of Comprehensive Income as a capital item. No other management fees are payable.

(e) Cash and cash equivalents

Cash comprises cash at hand and demand deposits. Cash equivalents, which include bank overdrafts, are short term, highly liquid investments that are readily convertible to known amounts of cash, are subject to insignificant risks of changes in value and are held for the purpose of meeting short-term cash commitments rather than for investment or other purposes.

(f) Taxation

Irrecoverable taxation on dividends is recognised on an accrual basis in the Statement of Comprehensive Income.

The Company is approved as an Investment Trust Company (ITC) under sections 1158 and 1159 of the Corporation Taxes Act 2010 and Part 2 Chapter 1 Statutory Instrument 2011/2999 for accounting periods commencing on or after 25 May 2018.

The approval is subject to the Company continuing to meet the eligibility conditions of the Corporations Tax Act 2010 and the Statutory Instrument 2011/2999. The Company intends to ensure that it complies with the ITC regulations on an ongoing basis and regularly monitors the conditions required to maintain ITC status.

5. Accounting policies (continued)

Current tax is the expected tax payable on any taxable income for the period, using tax rates enacted or substantively enacted at the end of the relevant period. The current tax rate is 25%.

The tax charges on Indian capital gains are shown in the Statement of Comprehensive Income, recognised on an accrual basis. The Company is not subject to UK capital gains tax.

Deferred taxat on

Deferred tax is the tax expected to be payable or recoverable on differences between the carrying amounts of assets and liabilities in the Financial Statements and the corresponding tax bases used in the computation of taxable profit and is accounted for using the statement of financial position liability method. Deferred tax liabilities are recognised for all taxable temporary differences and deferred tax assets are recognised to the extent that it is probable that taxable profits will be available against which deductible temporary differences can be utilised. Investment trusts which have approval as such under Section 1158 of the Corporation Tax Act 2010 are not liable for taxation on capital gains.

(g) Trade and other receivables

Trade and other receivables are recognised initially at fair value and subsequently stated at amortised cost less loss allowance which is determined using the simplified approach to measuring expected credit losses, the effect of which is considered immaterial.

(h)Trade and other payables

Trade and other payables are recognised initially at fair value and subsequently stated at amortised cost.

(i) Equity

Equity instruments issued by the Company are recorded at the amount of the proceeds received, net of directly attributable issue costs. Costs not directly attributable to the issue are immediately expensed in the Statement of Comprehensive Income.

(j) Investments

Upon initial recognition, investments are recognised at fair value through profit or loss. They are accounted for on the date they are traded and are included initially at fair value which is taken to be their cost. Subsequently investments held are valued at fair value.

Changes in the fair value of investments held at fair value through profit or loss and gains or losses on disposal are included in the capital column of the Statement of Comprehensive Income within "Net gain on investments held at fair value through profit and loss".

Investments are derecognised on the trade date of their disposal, which is the point where the Company transfers substantially all the risks and rewards of the ownership of the financial asset.

Transaction costs directly attributable to the acquisition of investments at fair value through profit or loss are recognised under gains/(losses) on investments.

Financial liabilites measured atamortsed cost

Recogniton and derecogniton

Impairmentof f nancial assets

For the period 15 March
2023 to 30 September
2023
£
The net gains on investments held during the period comprise:
Revaluation of investment market values 1,182,285
Currency losses (135, 505)
Net capital gains 1,046,780
For the period 15 March
2023 to 30 September
2023
£
Dividends 164,976
Bank interest 27,637
Total revenue 192,613
For the period 15 March
2023 to 30 September
2023
£
Administration Fees 65,210
AIC Annual Subscription 1,802
AIFM Fee 6,757
Auditors Remuneration 35,135
Custodian Fees 8,018
Director's Fees 40,768
Director's Insurance 6,054
Legal and professional fees 24,324
LSE (London Stock Exchange) Fees 35,945
Regulatory Expenses 330
Other expenses 67,452
Tax Advice Fee 13,164
Trade charges 7,442
Total operating expenses 312,401

9. Performance Fee Provision

The Investment Manager does not receive a fixed management fee in respect of its portfolio management services to the Company. The Investment Manager will become entitled to a performance fee subject to the Company delivering excess returns versus the MSCI Emerging Markets NR index. The performance fee will be measured over periods of three years (Performance Period), with the first period ending on 31 March 2026. Each subsequent performance period will run for a full 3-year period. The performance fee in any Performance Period shall be capped at 12% of the time weighted average adjusted net assets during the relevant Performance Period. The performance fee is calculated at a rate of 30% of the excess returns between adjusted NAV per share on the last day of the performance period and the MSCI Emerging Markets Net Total Return Index (in Sterling) over the performance period, adjusted for the weighted average number of Ordinary Shares in issue during the performance period.

The Performance Fee in respect of each Performance Period will be paid at the end of the three-year period. As at 30 September 2023, there was no provision for the performance fee liability to the Investment Manager.

The Company became liable to pay any performance fee following the investment of at least 70% of the initial net IPO proceeds, which occurred on 15 May 2023 as previously announced by the Company. From 15 May 2023 to 30 September 2023, no Alpha Fee has accrued as there was no outperformance over this period.

10. Taxation

The Company is recognised as an Investment Trust Company for accounting periods beginning on or after 15 March 2023 and is taxed at the main rate of 25%.

30 September 2023
£
Tax charge in profit or loss
a)
Indian Tax Charge 133,804
Withholding tax on dividends 20,172
Reconciliation of the tax charge for the period
b)
Profit before tax 926,992
Tax at UK main rate of 25% 231,748
Tax effect of:
Fair value gains on investments not taxable (261, 695)
Unrecognised tax losses 29,947
Foreign tax 153,976
Tax charge for the period 153,976

10. Taxation (continued)

Investment Trust Companies which have been approved by HM Revenue & Customs are exempt from UK corporation tax on their capital gains. Due to the Company's status as an approved Investment Trust Company, and the intention to continue meeting the conditions required to maintain that approval for the foreseeable future, the Company has not provided for deferred tax in respect of any gains or losses arising on the revaluation of its investments. Taxes are based on the UK Corporate tax rates which existed as of the balance sheet date which was 25%.

The Company has an unrecognised deferred UK Corporation tax asset of £29,947 based on the prospective UK corporation tax rate of 25%. This asset has accumulated because deductible expenses exceeded taxable income for the period ended 30 September 2023. No asset has been recognised in the accounts because, given the composition of the Company's portfolio, it is unlikely that this asset will be utilised in the foreseeable future.

The Company is liable to Indian capital gains tax under Section 115 AD of the Indian Income Tax Act 1961. A tax provision on Indian capital gains is calculated based on the long-term (securities held more than one year) or short-term (securities held less than one year) nature of the investments and the applicable tax rate at the period end. The short term tax rate is 15% and the long-term tax rate is 10%. A provision of £83,385 was raised at the end of the accounting period to account for this.

11. Investments held at fair value through profit or loss

30 September 2023
f
Investments held at fair value through profit or loss 29,490,772
Closing valuation 29,490,772

Under IFRS 13 'Fair Value Measurement', an entity is required to classify investments using a fair value hierarchy that reflects the significance of the inputs used in making the measurement decision.

The following shows the analysis of financial assets recognised at fair value based on:

Level 1

Inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date

Level 2

Inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly

Level 3

Inputs are unobservable (i.e. for which market data is unavailable) for the asset or liability.

As at 30 September 2023
Level 1 Level 2 Level 3 Total
Investments held at fair value through
profit or loss - Quoted investments
29,490,772 29,490,772
There were no transfers between levels from incorporation on 15 March 2023 to 30 September
2023.
30 September 2023
£
Opening Balance
Add: purchases during the period 58,079,552
Less: Sales during the period (29, 635, 560)
Total book cost 28,443,992
Total fair value movement through the profit or loss 1,046,780
Closing Balance 29,490,772
12. Cash and cash equivalents
£ 30 September 2023
Cash in bank 1,573,414
Total cash and cash equivalents 1,573,414
13. Trade and other receivables
30 September 2023
£
Accrued income 12,829
Amount receivable for sale of securities 123,365
Management shares receivable 50,000
Prepaid expenses 20,117
30 September 2023
£
Amount payable for purchase of securities 168,907
Expense Accruals 184,367
Forward exchange payable 105
IPO cost accrual payable 10,716
Total payables 364,095
5. Categories of financial instruments
30 September 2023
£
Financial assets
Financial assets at fair value through profit and loss:
Investments at fair value 29,490,772
Financial assets at amortised cost:
Trade and other receivables 206,311
Cash at bank 1,573,414
Total financial assets 31,270,497
Financial liabilities
Financial liabilities at amortised cost:
Trade and other payables 364,095
Total financial liabilities 364,095

I) Credit risk

ii) Currency risk

Managementof currency risks

iii) Liquidity risk

Managementof liquidity risks

16. Financial risk management (continued)

<1 year 1 to 2 years 2 to 5 years >5 years Total
£ £ £ £ £
Financial assets
Financial assets at
amortised cost:
Trade and other
receivables 206,311 206,311
Cash 1,573,414 1,573,414
Total financial
assets 1,779,725 1,779,725
Financial liabilities
Financial liabilities
at amortised cost:
Capital gains tax
provision
Trade and other
payables 364,095 364,095
Total financial
liabilities 364,095 364,095

The following table reflects the maturity analysis of financial assets and liabilities:

iv) Market risk

Market risk is the risk that the fair value or cash flows of a financial instrument will fluctuate adversely due to changes in market prices. Market risk reflects: (i) other price risks, and (ii) interest rate risk. The objective is to minimise market risk through managing and controlling these risks to acceptable parameters, while optimising returns. The Company may use financial instruments in the ordinary course of business to manage market risks.

Price risk and sensit vity

The Company's investments are susceptible to market price risk arising from uncertainties about the future values of the instruments.

Price risk is the risk that the fair value or cash flows of a financial instrument will fluctuate due to changes in market prices. At 30 September 2023, if the market prices of the securities had been 10% higher with all other variables held constant, the increase in net assets attributable to Shareholders for the period would have been £2,949,077 higher due to the increase in the fair value of financial instruments. A 10% decrease would have the equal and opposite effect.

16. Financial risk management (continued)

v) Interest rate risk

Interest rate risk is the risk of changes in the interest expense for debt, or interest received on deposits, as measured in the currency of that debt, due to movements in market interest rates. The Company does not have any borrowings as at 30 September 2023.

vi) Capital risk management

The capital structure of the Company at period end consists of equity attributable to equity holders of the Company, comprising issued capital, reserves and accumulated gains and losses. The Board continues to monitor the overall capital structure's balance to maintain investor and market confidence. The Company is not subject to any external capital requirements.

17. Share capital

As at 30 September 2023
No. of shares f
Ordinary shares of 1p each 30,532,279 305,323
Management shares 50,000 50,000
Total 30,582,279 355,323

On incorporation, 15 March 2023, the issued share capital of the Company was 1 ordinary share of 1 penny and 50,000 Management Shares of nominal value £1.00 each. On 3 May 2023, 30,532,278 ordinary shares were allotted and issued to Shareholders as part of the placing and offer for subscription in accordance with the Company's prospectus dated 18 April 2023. Following admission of the Company's Ordinary Shares to trading on the London Stock Exchange, the Directors applied to the Court to cancel the amount standing to the credit of the share premium account of the Company. On 12th September 2023, the share premium amount of £29,694,678 had been cancelled and credited to the Capital reduction reserve.

Reserves

The nature and purpose of each of the reserves included within the total equity of the Company as at 30 September 2023 are as follows:

• Share premium reserve: represents the surplus of the gross proceeds of share issues over the nominal value of the shares, net of the direct costs of equity issues and net of conversion amount.

• Capital reduction reserve: represents a distributable reserve created following a Court approved reduction in capital. This reserve is distributable and may be used, where the Board considers it appropriate, by the Company for the purpose of paying dividends to Shareholders.

• Revenue reserve: represents a distributable reserve of cumulative net gains and losses recognised in the Revenue account of the Statement of Comprehensive Income.

17. Share capital (continued)

• Capital Reserves: represents a non-distributable reserve of cumulative net capital gains and losses recognised in the Statement of Comprehensive Income.

The only movements in these reserves during the period are disclosed in the statement of changes in equity.

18. Net Asset per share (basic and diluted)

Basic NAV per share is calculated by dividing the Company's net assets as shown in the statement of financial position that are attributable to the ordinary equity holders of the Company by the number of ordinary shares outstanding at the end of the period. As there are no dilutive instruments outstanding, basic and diluted NAV per share is identical.

30 September 2023
£
Net assets per Statement of Financial Position 30,823,017
Ordinary shares in issue as at 30 September 2023 30,532,279
Management shares in issue 50,000
NAV per share – Basic and diluted (Pence) 100.79

19. Related party transactions

There are no fees payable to the Investment Manager.

Since commencement of operations on 3 May 2023 fees have been payable at an annual rate of £35,000 to the Chairman, £30,000 to the Chair of the Audit Committee, and £27,500 to the other Director.

As at period end, there are no fees payable to the Investment Manager. Refer to Note 9 for detail on the Investment Manager's performance fee.

The Directors had the following shareholdings in the Company, all of which are beneficially owned.

Martin Shenfield 40,000 shares
Tanit Curry 20,000 shares
Howard Pearce 20,000 shares

20. Post balance sheet events

Subsequent to 30 September 2023 the Company issued the following new Ordinary Shares of one penny each pursuant to its block listing facility at a premium to the prevailing net asset value per Ordinary Share.

Date of issue No. of shares issued Price per Ordinary Share
5 October 2023 998.530 101.00 pence
21 November 2023 100,000 104.00 pence
23 November 2023 200,000 103.90 pence
30 November 2023 135,000 102.70 pence
1 December 2023 130,000 102.40 pence
5 December 2023 100,000 101.30 pence

Following the above issue of Ordinary Shares, the Company's issued share capital comprised 32,195,809 Ordinary Shares and this is the total number of Ordinary Shares with voting rights in the Company.

The Company operates a voluntary redemption facility through which Shareholders may request the redemption of all or part of their holding of redeemable ordinary shares of one penny each in the Company for cash on the last Business Day in December each year. As at 6 December 2023, the latest date for receipt of Redemption Requests, 14,014 shares were submitted for redemption.

ALTERNATIVE PERFORMANCE MEASURES (unaudited)

Ordinary share price to NAV discount (unaudited)

The amount, expressed as a percentage, by which the share price is less than the Net Asset Value per Ordinary Share.

As at 30 September 2023

Discount (unaudited) $(a+b)-1$ 0.79%
Share price (b) 100.00
NAV per share (a) 100.79

Share price/NAV total Return (unaudited)

A measure of performance that includes both income and capital returns. This takes into account capital gains and reinvestment of dividends paid out by the Company into the Ordinary Shares of the Company on the ex-dividend date.

Period from 3 May 2023 unt I 30 September 2023

Share Price NAV
Opening - 3 May 2023 (a) 100.00 98.26
Closing - 30 September 2023 (b) 100.00 100.79
Total Return $(b \div a) - 1$ $0.00\%$ 2.60%

Talk to a Data Expert

Have a question? We'll get back to you promptly.